iRhythm® Technologies Names Quentin Blackford President and Chief Executive Officer
SAN FRANCISCO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Quentin Blackford has been appointed President and Chief Executive Officer of iRhythm and a member of the Board of Directors (the “Board”), effective October 4, 2021.
Mr. Blackford is an accomplished industry leader, bringing more than 20 years of experience scaling premier innovative medical device and digital health companies, including most recently as Chief Operating Officer of Dexcom, Inc., a leader of diabetes care technology. In that role, he was responsible for global operations, corporate strategy and expansion into new markets, helping guide the company during a period of significant growth and transformation.
“Quentin is a world-class leader who has been at the center of growth and market expansion at multiple premier medtech companies,” commented Abhijit Talwalkar, Chairman of the iRhythm Board. “Quentin has a strong track record of engaging teams to instill excellence across global operations. He shares our commitment to innovation and appreciates the important role it has in improving lives. We are delighted to welcome him to iRhythm to drive our next phase of growth.”
“I am excited to be joining iRhythm as CEO,” said Mr. Blackford. “iRhythm’s business is built around innovative technology with differentiated capabilities that providers and patients value. This is a powerful platform for growth and I am looking forward to joining the iRhythm team to help capitalize on the company’s many opportunities."
Douglas Devine will continue to serve as the Interim Chief Executive Officer until Mr. Blackford joins the company on October 4th, 2021.
Mr. Talwalkar continued, “We are immensely grateful to Doug for his leadership and steady hand over these past weeks as interim CEO. is commitment to iRhythm and our stakeholders helped ensure a smooth transition period and continued progression on our operating plans. He is a valuable member of our executive management team.”
About Quentin Blackford
Prior to Dexcom, Mr. Blackford served as NuVasive’s Executive Vice President, Chief Financial Officer, Head of Strategy and Corporate Integrity, where he played a key role in navigating the company through phases of significant growth and profitability improvements since 2009. He was instrumental in several acquisitions to build upon NuVasive’s portfolio of products and entry into new product segments, as well as geographic expansion.
Prior to his roles at NuVasive, Mr. Blackford led the organization’s Global Financial Planning & Analysis group at Zimmer Holdings, Inc., in addition to serving as Director of Finance and Controller of the Dental Division.
Mr. Blackford is an independent member of the Board of Directors of Alphatec Holdings, Inc. and Axogen, Inc.
Mr. Blackford is a Certified Public Accountant (inactive) and received dual Bachelor of Science degrees in Accounting and Business Administration from Grace College.
About iRhythm Technologies, Inc.
Moving Things and 5G Low Latency
Presentation Details TBA
Getting to the Relevant (meta) Data